{
    "xml": "<topic id=\"PHP1348\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/nicardipine-hydrochloride\" basename=\"nicardipine-hydrochloride\" title=\"NICARDIPINE HYDROCHLORIDE\">\n<title>NICARDIPINE HYDROCHLORIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_474\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/calcium-channel-blockers-dihydropyridines/nicardipine\">Nicardipine</xref>\n</p>\n<data name=\"vtmid\">108526002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_762273848\" title=\"Calcium-channel blockers\">Calcium-channel blockers</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34525\" title=\"CALCIUM-CHANNEL BLOCKERS\" namespace=\"/drug-classes/calcium-channel-blockers\">CALCIUM-CHANNEL BLOCKERS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP70908\" outputclass=\"drugAction\" rev=\"1.7\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Nicardipine is a dihydropyridine calcium-channel blocker.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58153\" outputclass=\"indicationsAndDose\" rev=\"1.65\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of angina</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using immediate-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 20&#8239;mg 3 times a day, then increased to 30&#8239;mg 3 times a day, dose increased after at least 3 days; usual dose 60&#8211;120&#8239;mg daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mild to moderate hypertension</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using immediate-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 20&#8239;mg 3 times a day, then increased to 30&#8239;mg 3 times a day, dose increased after at least 3 days; usual dose 60&#8211;120&#8239;mg daily.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By mouth using modified-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 30&#8239;mg twice daily; increased if necessary up to 45&#8239;mg twice daily. usual dose 30&#8211;60&#8239;mg twice daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Life-threatening hypertension (specialist use only)</p>\n<p outputclass=\"therapeuticIndication\">Post-operative hypertension (specialist use only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By continuous intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 3&#8211;5&#8239;mg/hour for 15 minutes, increased in steps of 0.5&#8211;1&#8239;mg every 15&#8239;minutes, adjusted according to response, maximum rate 15&#8239;mg/hour, reduce dose gradually when target blood pressure achieved; maintenance 2&#8211;4&#8239;mg/hour.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Initially 1&#8211;5&#8239;mg/hour, then adjusted in steps of 500&#8239;micrograms/hour after 30&#8239;minutes, adjusted according to response, maximum rate 15&#8239;mg/hour.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Life-threatening hypertension in patients with hepatic or renal impairment (specialist use only)</p>\n<p outputclass=\"therapeuticIndication\">Postoperative hypertension in patients with hepatic or renal impairment (specialist use only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By continuous intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 1&#8211;5&#8239;mg/hour, then adjusted in steps of 500&#8239;micrograms/hour after 30&#8239;minutes, adjusted according to response, maximum rate 15&#8239;mg/hour.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Acute life-threatening hypertension in pregnancy (specialist use only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By continuous intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 1&#8211;5&#8239;mg/hour, then adjusted in steps of 500&#8239;micrograms/hour after 30&#8239;minutes, adjusted according to response, usual maximum rate 4&#8239;mg/hour in treatment of pre-eclampsia (maximum rate 15&#8239;mg/hour).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69105\" outputclass=\"contraindications\" rev=\"1.50\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Contra-indications</title>\n<body>\r\n<section outputclass=\"contraindications\">\r\n<title>General contraindications:</title>\r\n<p>\r\n<ph outputclass=\"contraindication\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"contraindication\">cardiogenic shock</ph>; <ph outputclass=\"contraindication\">significant or advanced aortic stenosis</ph>; <ph outputclass=\"contraindication\">unstable or acute attacks of angina</ph>\r\n</p>\r\n<sectiondiv outputclass=\"additionalContraindications\">\r\n<p outputclass=\"title\">Specific contraindications:</p>\r\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\r\n<p outputclass=\"title\">With intravenous use</p>\r\n<p>\r\n<ph outputclass=\"contraindication\">avoid within 8 days of myocardial infarction</ph>; <ph outputclass=\"contraindication\">compensatory hypertension</ph>\r\n</p>\n</sectiondiv>\r\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\r\n<p outputclass=\"title\">With oral use</p>\r\n<p>\r\n<ph outputclass=\"contraindication\">avoid within 1 month of myocardial infarction</ph>\r\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP68318\" outputclass=\"cautions\" rev=\"1.28\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Congestive heart failure</ph>; <ph outputclass=\"caution\">elderly</ph>; <ph outputclass=\"caution\">elevated intracranial pressure</ph>; <ph outputclass=\"caution\">portal hypertension</ph>; <ph outputclass=\"caution\">pulmonary oedema</ph>; <ph outputclass=\"caution\">significantly impaired left ventricular function</ph>; <ph outputclass=\"caution\">stroke</ph>; <ph outputclass=\"caution\">withdraw if ischaemic pain occurs or existing pain worsens within 30 minutes of initiating treatment or increasing dose</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54511\" outputclass=\"interactions\" rev=\"1.9\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (calcium-channel blockers).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP42234\" outputclass=\"sideEffects\" rev=\"1.38\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Atrioventricular block</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">flushing</ph>; <ph outputclass=\"sideEffect\">frequency of micturition</ph>; <ph outputclass=\"sideEffect\">gastro-intestinal disturbances</ph>; <ph outputclass=\"sideEffect\">gingival hyperplasia</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">impotence</ph>; <ph outputclass=\"sideEffect\">insomnia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">palpitations</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">paralytic ileus</ph>; <ph outputclass=\"sideEffect\">peripheral oedema</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">pulmonary oedema</ph>; <ph outputclass=\"sideEffect\">rashes</ph>; <ph outputclass=\"sideEffect\">tachycardia</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">tinnitus</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Hypotension and reflex tachycardia</p>\n<p>Systemic hypotension and reflex tachycardia with rapid reduction of blood pressure may occur&#8212;during intravenous use consider stopping infusion or decreasing dose by half.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsOverdosageInformation\">\n<title>Overdose</title>\n<sectiondiv>\n<p>In overdose, the dihydropyridine calcium-channel blockers cause severe hypotension secondary to profound peripheral vasodilatation.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP52818\" outputclass=\"pregnancy\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>For treatment of acute life-threatening hypertension only.</p>\n</sectiondiv>\n<sectiondiv>\n<p>May inhibit labour. Not to be used in multiple pregnancy (twins or more) unless there is no other acceptable alternative. Toxicity in <i>animal</i> studies. Risk of severe maternal hypotension and fatal foetal hypoxia&#8212;avoid excessive decrease in blood pressure.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP46935\" outputclass=\"breastFeeding\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;present in breast milk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60095\" outputclass=\"hepaticImpairment\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Use with caution&#8212;consider using lowest initial dose and extending dosing interval according to individual response.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Use with caution&#8212;use lower initial dose.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP45141\" outputclass=\"renalImpairment\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Consider using lowest initial dose and extending dosing interval according to individual response. </p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Use with caution&#8212;use lower initial dose.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP51273\" outputclass=\"monitoringRequirements\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Monitor blood pressure and heart rate at least every 5 minutes during intravenous infusion, and then until stable, and continue monitoring for at least 12 hours after end of infusion.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP65490\" outputclass=\"directionsForAdministration\" rev=\"1.29\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Intravenous nicardipine should only be administered under the supervision of a specialist and in a hospital or intensive care setting in which patients can be closely monitored.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion </i> give continuously <i>in</i> Glucose 5%; dilute dose in infusion fluid to a final concentration of 100&#8211;200&#8239;micrograms/mL (undiluted solution <i>via</i> central venous line only) and give <i>via</i> volumetric infusion pump or syringe driver; protect from light; to minimise peripheral venous irritation, change site of infusion every 12 hours; risk of adsorption on to plastic of infusion set in the presence of saline solutions; incompatible with bicarbonate or alkaline solutions&#8212;consult product literature.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1348-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/nicardipine-hydrochloride\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74923\" title=\"Capsule\" namespace=\"/drugs/nicardipine-hydrochloride/capsule\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74918\" title=\"Modified-release capsule\" namespace=\"/drugs/nicardipine-hydrochloride/modified-release-capsule\">Modified-release capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74929\" title=\"Solution for infusion\" namespace=\"/drugs/nicardipine-hydrochloride/solution-for-infusion\">Solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78099\" namespace=\"/treatment-summaries/hypertension\" title=\"Hypertension\" count=\"1\" rel=\"backlink\">Hypertension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78483\" namespace=\"/treatment-summaries/calcium-channel-blockers\" title=\"Calcium-channel blockers\" count=\"6\" rel=\"backlink\">Calcium-channel blockers</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_474\" namespace=\"/interactions/list-of-drug-interactions/calcium-channel-blockers/calcium-channel-blockers-dihydropyridines/nicardipine\" title=\"Nicardipine\" count=\"1\" rel=\"link\">Nicardipine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34525\" namespace=\"/drug-classes/calcium-channel-blockers\" title=\"CALCIUM-CHANNEL BLOCKERS\" count=\"1\" rel=\"link\">CALCIUM-CHANNEL BLOCKERS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74923\" namespace=\"/drugs/nicardipine-hydrochloride/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74918\" namespace=\"/drugs/nicardipine-hydrochloride/modified-release-capsule\" title=\"Modified-release capsule\" count=\"1\" rel=\"link\">Modified-release capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74929\" namespace=\"/drugs/nicardipine-hydrochloride/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP1348",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/nicardipine-hydrochloride",
    "basename": "nicardipine-hydrochloride",
    "title": "NICARDIPINE HYDROCHLORIDE",
    "interactants": [
        {
            "id": "bnf_int_474",
            "label": "Nicardipine"
        }
    ],
    "vtmid": "108526002",
    "drugClassification": [
        "Calcium-channel blockers"
    ],
    "inheritsFromClass": [
        "CALCIUM-CHANNEL BLOCKERS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Nicardipine is a dihydropyridine calcium-channel blocker.",
                "html": "<p>Nicardipine is a dihydropyridine calcium-channel blocker.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of angina",
                        "html": "Prophylaxis of angina"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using immediate-release medicines"
                    ],
                    "textContent": "By mouth using immediate-release medicines",
                    "html": "By mouth using immediate-release medicines"
                },
                "adult": [
                    {
                        "textContent": "Initially 20 mg 3 times a day, then increased to 30 mg 3 times a day, dose increased after at least 3 days; usual dose 60&#8211;120 mg daily.",
                        "html": "<p>Initially 20&#8239;mg 3 times a day, then increased to 30&#8239;mg 3 times a day, dose increased after at least 3 days; usual dose 60&#8211;120&#8239;mg daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Mild to moderate hypertension",
                        "html": "Mild to moderate hypertension"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using modified-release medicines"
                    ],
                    "textContent": "By mouth using modified-release medicines",
                    "html": "By mouth using modified-release medicines"
                },
                "adult": [
                    {
                        "textContent": "Initially 20 mg 3 times a day, then increased to 30 mg 3 times a day, dose increased after at least 3 days; usual dose 60&#8211;120 mg daily.",
                        "html": "<p>Initially 20&#8239;mg 3 times a day, then increased to 30&#8239;mg 3 times a day, dose increased after at least 3 days; usual dose 60&#8211;120&#8239;mg daily.</p>"
                    },
                    {
                        "textContent": "Initially 30 mg twice daily; increased if necessary up to 45 mg twice daily. usual dose 30&#8211;60 mg twice daily.",
                        "html": "<p>Initially 30&#8239;mg twice daily; increased if necessary up to 45&#8239;mg twice daily. usual dose 30&#8211;60&#8239;mg twice daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Life-threatening hypertension (specialist use only)",
                        "html": "Life-threatening hypertension (specialist use only)"
                    },
                    {
                        "textContent": "Post-operative hypertension (specialist use only)",
                        "html": "Post-operative hypertension (specialist use only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "continuous intravenous infusion"
                    ],
                    "textContent": "By continuous intravenous infusion",
                    "html": "By continuous intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 3&#8211;5 mg/hour for 15 minutes, increased in steps of 0.5&#8211;1 mg every 15 minutes, adjusted according to response, maximum rate 15 mg/hour, reduce dose gradually when target blood pressure achieved; maintenance 2&#8211;4 mg/hour.",
                        "html": "<p>Initially 3&#8211;5&#8239;mg/hour for 15 minutes, increased in steps of 0.5&#8211;1&#8239;mg every 15&#8239;minutes, adjusted according to response, maximum rate 15&#8239;mg/hour, reduce dose gradually when target blood pressure achieved; maintenance 2&#8211;4&#8239;mg/hour.</p>"
                    },
                    {
                        "textContent": "Initially 1&#8211;5 mg/hour, then adjusted in steps of 500 micrograms/hour after 30 minutes, adjusted according to response, maximum rate 15 mg/hour.",
                        "html": "<p>Initially 1&#8211;5&#8239;mg/hour, then adjusted in steps of 500&#8239;micrograms/hour after 30&#8239;minutes, adjusted according to response, maximum rate 15&#8239;mg/hour.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Life-threatening hypertension in patients with hepatic or renal impairment (specialist use only)",
                        "html": "Life-threatening hypertension in patients with hepatic or renal impairment (specialist use only)"
                    },
                    {
                        "textContent": "Postoperative hypertension in patients with hepatic or renal impairment (specialist use only)",
                        "html": "Postoperative hypertension in patients with hepatic or renal impairment (specialist use only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "continuous intravenous infusion"
                    ],
                    "textContent": "By continuous intravenous infusion",
                    "html": "By continuous intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 1&#8211;5 mg/hour, then adjusted in steps of 500 micrograms/hour after 30 minutes, adjusted according to response, maximum rate 15 mg/hour.",
                        "html": "<p>Initially 1&#8211;5&#8239;mg/hour, then adjusted in steps of 500&#8239;micrograms/hour after 30&#8239;minutes, adjusted according to response, maximum rate 15&#8239;mg/hour.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Acute life-threatening hypertension in pregnancy (specialist use only)",
                        "html": "Acute life-threatening hypertension in pregnancy (specialist use only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "continuous intravenous infusion"
                    ],
                    "textContent": "By continuous intravenous infusion",
                    "html": "By continuous intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 1&#8211;5 mg/hour, then adjusted in steps of 500 micrograms/hour after 30 minutes, adjusted according to response, usual maximum rate 4 mg/hour in treatment of pre-eclampsia (maximum rate 15 mg/hour).",
                        "html": "<p>Initially 1&#8211;5&#8239;mg/hour, then adjusted in steps of 500&#8239;micrograms/hour after 30&#8239;minutes, adjusted according to response, usual maximum rate 4&#8239;mg/hour in treatment of pre-eclampsia (maximum rate 15&#8239;mg/hour).</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "contraindications",
                "textContent": "cardiogenic shock",
                "html": "cardiogenic shock"
            },
            {
                "type": "contraindications",
                "textContent": "significant or advanced aortic stenosis",
                "html": "significant or advanced aortic stenosis"
            },
            {
                "type": "contraindications",
                "textContent": "unstable or acute attacks of angina",
                "html": "unstable or acute attacks of angina"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid within 8 days of myocardial infarction",
                "html": "avoid within 8 days of myocardial infarction",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "compensatory hypertension",
                "html": "compensatory hypertension",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "avoid within 1 month of myocardial infarction",
                "html": "avoid within 1 month of myocardial infarction",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ]
                }
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Congestive heart failure",
                "html": "Congestive heart failure"
            },
            {
                "type": "cautions",
                "textContent": "elderly",
                "html": "elderly"
            },
            {
                "type": "cautions",
                "textContent": "elevated intracranial pressure",
                "html": "elevated intracranial pressure"
            },
            {
                "type": "cautions",
                "textContent": "portal hypertension",
                "html": "portal hypertension"
            },
            {
                "type": "cautions",
                "textContent": "pulmonary oedema",
                "html": "pulmonary oedema"
            },
            {
                "type": "cautions",
                "textContent": "significantly impaired left ventricular function",
                "html": "significantly impaired left ventricular function"
            },
            {
                "type": "cautions",
                "textContent": "stroke",
                "html": "stroke"
            },
            {
                "type": "cautions",
                "textContent": "withdraw if ischaemic pain occurs or existing pain worsens within 30 minutes of initiating treatment or increasing dose",
                "html": "withdraw if ischaemic pain occurs or existing pain worsens within 30 minutes of initiating treatment or increasing dose"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (calcium-channel blockers).",
                "html": "<p>Appendix 1 (calcium-channel blockers).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Atrioventricular block",
                        "html": "Atrioventricular block",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "flushing",
                        "html": "flushing",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "frequency of micturition",
                        "html": "frequency of micturition",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-intestinal disturbances",
                        "html": "gastro-intestinal disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gingival hyperplasia",
                        "html": "gingival hyperplasia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "impotence",
                        "html": "impotence",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "insomnia",
                        "html": "insomnia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "palpitations",
                        "html": "palpitations",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paraesthesia",
                        "html": "paraesthesia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paralytic ileus",
                        "html": "paralytic ileus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "peripheral oedema",
                        "html": "peripheral oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pulmonary oedema",
                        "html": "pulmonary oedema",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tachycardia",
                        "html": "tachycardia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "tinnitus",
                        "html": "tinnitus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Hypotension and reflex tachycardia",
                "textContent": "Systemic hypotension and reflex tachycardia with rapid reduction of blood pressure may occur&#8212;during intravenous use consider stopping infusion or decreasing dose by half.",
                "html": "<p>Systemic hypotension and reflex tachycardia with rapid reduction of blood pressure may occur&#8212;during intravenous use consider stopping infusion or decreasing dose by half.</p>"
            }
        ],
        "overdosageInformation": [
            {
                "type": "overdosageInformation",
                "textContent": "In overdose, the dihydropyridine calcium-channel blockers cause severe hypotension secondary to profound peripheral vasodilatation.",
                "html": "<p>In overdose, the dihydropyridine calcium-channel blockers cause severe hypotension secondary to profound peripheral vasodilatation.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "For treatment of acute life-threatening hypertension only.",
                "html": "<p>For treatment of acute life-threatening hypertension only.</p>"
            },
            {
                "type": "generalInformation",
                "textContent": "May inhibit labour. Not to be used in multiple pregnancy (twins or more) unless there is no other acceptable alternative. Toxicity in animal studies. Risk of severe maternal hypotension and fatal foetal hypoxia&#8212;avoid excessive decrease in blood pressure.",
                "html": "<p>May inhibit labour. Not to be used in multiple pregnancy (twins or more) unless there is no other acceptable alternative. Toxicity in <i>animal</i> studies. Risk of severe maternal hypotension and fatal foetal hypoxia&#8212;avoid excessive decrease in blood pressure.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;present in breast milk.",
                "html": "<p>Manufacturer advises avoid&#8212;present in breast milk.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Use with caution&#8212;consider using lowest initial dose and extending dosing interval according to individual response.",
                "html": "<p>Use with caution&#8212;consider using lowest initial dose and extending dosing interval according to individual response.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Use with caution&#8212;use lower initial dose.",
                "html": "<p>Use with caution&#8212;use lower initial dose.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Consider using lowest initial dose and extending dosing interval according to individual response.",
                "html": "<p>Consider using lowest initial dose and extending dosing interval according to individual response. </p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Use with caution&#8212;use lower initial dose.",
                "html": "<p>Use with caution&#8212;use lower initial dose.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Monitor blood pressure and heart rate at least every 5 minutes during intravenous infusion, and then until stable, and continue monitoring for at least 12 hours after end of infusion.",
                "html": "<p>Monitor blood pressure and heart rate at least every 5 minutes during intravenous infusion, and then until stable, and continue monitoring for at least 12 hours after end of infusion.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Intravenous nicardipine should only be administered under the supervision of a specialist and in a hospital or intensive care setting in which patients can be closely monitored.",
                "html": "<p>Intravenous nicardipine should only be administered under the supervision of a specialist and in a hospital or intensive care setting in which patients can be closely monitored.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion give continuously in Glucose 5%; dilute dose in infusion fluid to a final concentration of 100&#8211;200 micrograms/mL (undiluted solution via central venous line only) and give via volumetric infusion pump or syringe driver; protect from light; to minimise peripheral venous irritation, change site of infusion every 12 hours; risk of adsorption on to plastic of infusion set in the presence of saline solutions; incompatible with bicarbonate or alkaline solutions&#8212;consult product literature.",
                "html": "<p>For <i>intravenous infusion </i> give continuously <i>in</i> Glucose 5%; dilute dose in infusion fluid to a final concentration of 100&#8211;200&#8239;micrograms/mL (undiluted solution <i>via</i> central venous line only) and give <i>via</i> volumetric infusion pump or syringe driver; protect from light; to minimise peripheral venous irritation, change site of infusion every 12 hours; risk of adsorption on to plastic of infusion set in the presence of saline solutions; incompatible with bicarbonate or alkaline solutions&#8212;consult product literature.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74923",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74918",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74929",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78099",
                "label": "Hypertension",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78483",
                "label": "Calcium-channel blockers",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_474",
                "label": "Nicardipine",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34525",
                "label": "CALCIUM-CHANNEL BLOCKERS",
                "type": "drugClass"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74923",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74918",
                "label": "Modified-release capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP74929",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}